Cell Death & Disease
Nature Publishing Group UK
image
Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model
Volume: 10, Issue: 5
DOI 10.1038/s41419-019-1606-1
  • PDF   
  • XML   
  •       

Highlights

Notes

Qiao, Wang, Yu, Han, Liu, Wang, Fan, Qin, and Tang: Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model

Retraction Note to:

Cell Death and Disease (2016)7:e2094

10.1038/cddis.2016.11 published online 11 February 2016

This article has been retracted at the request of the authors. After publication, the authors found that in Fig. 2B-a the first two images in the third row partly overlapped and that there is also overlap between the fourth and fifth images in the second row. The two images were taken from two adjacent wells, treated by ZA 0.3 μM-CM or ZA 0.75 μM-CM, with or without PL 1.25 μM. This overlap may have been caused by mishandling in the imaging process when the authors made microscope observations and so the findings are no longer reliable. All authors agree to this retraction.

https://www.researchpad.co/tools/openurl?pubtype=article&doi=10.1038/s41419-019-1606-1&title=Retraction Note: Structural simulation of adenosine phosphate via plumbagin and zoledronic acid competitively targets JNK/Erk to synergistically attenuate osteoclastogenesis in a breast cancer model&author=H. Qiao,T. Y. Wang,Z. F. Yu,X. G. Han,X. Q. Liu,Y. G. Wang,Q. M. Fan,A. Qin,T. T. Tang,&keyword=&subject=Retraction Note,